[Activation of periphery group III metabotropic glutamate receptors inhibits formalin-induced activation of spinal p38-MAPK in rats]. 2009

Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
Department of Anesthesiology, the First Hospital of Shanxi Medical University, Taiyuan 030001, China.

OBJECTIVE To explore the effects of periphery injection of L-SOP on the activation of p38MAPK in spinal cord in formalin pain model in rats. METHODS Fourty-eight male Wistar rats were divided randomly into four groups (n=12): NS group and three different dose of L-SOP groups. For each group, 6 rats used to observe flinching and licking time every as nociception behavior 3 minutes in 1 hour after formalin injected and the other 6 rats used to observe the activation of p38(P-p38) by Western blotting. RESULTS All the three different groups of L-SOP could inhibit nociception behavior in the tonic phase,and 250 nmoVl/L and 500 nmol/L groups could suppress not only in the tonic phase but also in the acute phase. 250 nmol/L and 500 nmol/L groups could reduce activated or phosphorylated p38MAPK in spinal cord. CONCLUSIONS Periphery injection of L-SOP can reduce nociceptive behavior and phosphorylated p38MAPK in the spinal cord in formalin-induced hyperalgia, it is suggested that there is functional expression of mGluRs III in the periphery and is involved in the processing of peripheral noxious informations.

UI MeSH Term Description Entries
D008297 Male Males
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010768 Phosphoserine The phosphoric acid ester of serine. Serine Phosphate,Phosphorylserine,Seryl Phosphate,Phosphate, Serine,Phosphate, Seryl
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D005557 Formaldehyde A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) Formalin,Formol,Methanal,Oxomethane
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D048051 p38 Mitogen-Activated Protein Kinases A mitogen-activated protein kinase subfamily that regulates a variety of cellular processes including CELL GROWTH PROCESSES; CELL DIFFERENTIATION; APOPTOSIS; and cellular responses to INFLAMMATION. The P38 MAP kinases are regulated by CYTOKINE RECEPTORS and can be activated in response to bacterial pathogens. Mitogen-Activated Protein Kinase p38,p38 Mitogen-Activated Protein Kinase,p38 MAP Kinase,p38 MAPK,p38 Protein Kinase,p38 SAPK,MAP Kinase, p38,MAPK, p38,Mitogen Activated Protein Kinase p38,Protein Kinase, p38,p38 Mitogen Activated Protein Kinase,p38 Mitogen Activated Protein Kinases
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
February 2022, Clinical and experimental pharmacology & physiology,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
September 2002, Pharmacology, biochemistry, and behavior,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
July 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
August 1996, European journal of pharmacology,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
January 2002, Experimental neurology,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
August 2006, Journal of neuroscience research,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
January 2002, Visual neuroscience,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
January 2008, Current medicinal chemistry,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
December 2013, Frontiers of medicine,
Xiao-chun Yan, and Zhi-feng Peng, and Xiao-rong Yang, and Xin Zhao, and Nai-hong Liu, and Xing Jin, and Qiao Cheng, and Ce Zhang
June 1997, Neuropharmacology,
Copied contents to your clipboard!